Prepared for Health Canada
Supplier name: Advanis Inc.
Contract number: HT372-204311/001/CY
Contract value: $249,730.00 (including HST)
Award date: January 18, 2021
Delivery date: July 8, 2021
Registration number: POR 102-20
For more information on this report, please contact Health Canada at:
hc.cpab.por-rop.dgcap.sc@canada.ca
Ce rapport est aussi disponible en Français.
The Canadian Cannabis Survey 2021
Methodological Report
Prepared for Health Canada
Supplier name: Advanis Inc.
July 2021
This public opinion research report presents the results of an online survey conducted by Advanis Inc. on behalf of Health Canada. The research was conducted with 10,736 Canadians between April 7th and June 28th, 2021.
This publication may be reproduced for non-commercial purposes only. Prior written permission must be obtained from Health Canada. For more information on this report, please contact Health Canada at: hc.cpab.por-rop.dgcap.sc@canada.ca or at:
Health Canada, CPAB
200 Eglantine Driveway, Tunney's Pasture
Jeanne Mance Building, AL 1915C
Ottawa, Ontario K1A 0K9
Catalogue number:
H21-312/2021E-PDF
International Standard Book Number (ISBN):
978-0-660-39834-1
Related publications (registration number: POR 102-20):
Catalogue number H21-312/2021F-PDF (Final report, French)
ISBN 978-0-660-39835-8
© Her Majesty the Queen in Right of Canada, as represented by the Minister of Health, 2021
Use of cannabis is common in Canada. In 2017, Health Canada's Canadian Tobacco, Alcohol and Drugs Survey (CTADS) found that 15% of respondents 15 years of age and older reported using cannabis in the past year, with males reporting use more often than females. Canadians 15 to 24 years old were significantly more likely to use cannabis in the past 12 months than those 25 years of age and older. Use is also common in students, with 18% of students in grades 7 to 12 reporting past year use in the 2018-2019 Canadian Student Tobacco, Alcohol and Drugs Survey (CSTADS). International data for cannabis from 2018 shows the United States had a lifetime prevalence rate of 45.3% 1, while Canada had a similar prevalence rate of 46.6% 2. Prevalence rates for past year cannabis use were highest in North America (14.6%) when compared to other regions (Australia and New Zealand (10.6%); West and Central Africa (9.3%); Europe (5.4%); Asia (1.9%)) around the world 3.
In the 2015 Speech from the Throne, the Government of Canada committed to legalizing, regulating, and restricting access to marijuana. In 2016, the Government's Task Force on Marijuana Legalization and Regulation issued a discussion paper entitled "Toward the legalization, regulation and restriction of access to marijuana" that initiated wider consultations and dialogue regarding its intention in this area (see: http://healthycanadians.gc.ca/health-system-systeme-sante/consultations/legalization-marijuana-legalisation/alt/legalization-marijuana-legalisation-eng.pdf for more information). In 2017, Bill C-45, an Act respecting cannabis and to amend the Controlled Drugs and Substances Act, the Criminal Code and other Acts, was introduced in the House of Commons. Implementation of the new Cannabis Act occurred in October 2018, creating a regulated legal market for non-medical cannabis for adults in Canada.
The legalization and regulation of cannabis in Canada has also prompted a policy and scientific requirement to collect new comprehensive data on the subject of cannabis use and non-use, including indicators in the areas of health, public safety, and markets. New research on cannabis use is helping the government better evaluate the possible impacts associated with its legalization, regulation, and restriction. In May and June 2016, Health Canada conducted the Baseline Survey on Awareness, Knowledge and Behaviour Associated with Recreational Use of Marijuana (administered by Ekos Research Associates). This study examined knowledge, perceived acceptability and health risks, patterns of recreational use, and information-seeking behaviours. This study found that 58% of respondents reported cannabis use in their lifetime and 22% reported use in the past 12 months. Among those who did not report use in the past 12 months, 85% felt they were unlikely to use cannabis once it becomes legal.
The Canadian Cannabis Survey was first conducted in 2017 and is an annual online survey. It examined, in more depth, patterns of use, such as the quantities of cannabis consumed and the use of cannabis for medical purposes; the cannabis market, such as sources of cannabis and pricing; and issues of public safety, such as impaired driving. The 2019 Canadian Cannabis Survey aimed to gather additional data, such as changes to willingness to publicly report cannabis use since legalization; exposure to education campaigns, public health or safety messages; respondents' usual source of cannabis products since the Cannabis Act came into effect; and relative levels of THC and CBD typically used. In 2021, Health Canada conducted the fifth cycle of the Canadian Cannabis Survey (CCS). It was in the field from April 7, 2021 to June 28, 2021 and collected data from almost 11,000 people 16 years of age and older. New content in 2021 included questions about exposure to second-hand cannabis smoke/vapour, home growing and the preparation of edibles in the home, more details on products and devices used when vapourizing cannabis, frequency of obtaining cannabis from legal and illegal sources, and changes in cannabis use due to the COVID-19 pandemic. Of the responses that were received, approximately 3,900 responses were from people who indicated that they had used cannabis in the past 12 months for either non-medical or medical purposes.
The 2021 Canadian Cannabis Survey aimed to gather additional information to track changes in data collected from the 2017, 2018, 2019 and 2020 surveys. The objectives of the 2021 survey were to collect information on the following:
The total cost of this research was $249,730.00 including HST.
The approach used was a two-step recruitment process where respondents were first recruited by telephone (both landline and mobile) using a short battery of screener questions approved by Health Canada, and consistent with the previous cycles. Respondents who completed the screener questions and qualified for the survey were then sent a link to the online survey, either by email or SMS, depending on their preference. Respondents were recruited from lists of random telephone numbers (RDD) that Advanis verified were in service. The distribution of phone numbers was approximately 85 percent mobile phones and 15 percent landline numbers.
The rationale for using a higher volume of cell phone than landline numbers came from the requirement of oversampling youth aged 16 to 24 years old. From previous experience, we know that this group is very hard to reach by conventional landline for two major reasons; first, they use their parents' landline and we have difficulty reaching them; second, if they have left their parents' house, they most likely use a cell phone rather than a landline.
In total, we called 129,902 phone numbers, and 19,809 people agreed to participate in the survey. Of these calls, 14 percent were conducted in French and 86 percent were conducted in English. The response rate achieved in 2021 was 21.1%. The response rate calculation is presented in Appendix A.
During the computer assisted telephone interviews (CATI) recruit, Advanis requested permission to send the survey link to respondents' mobile phones via a Short Message Service (SMS). The advantage of SMS survey invitations are that, unlike email invitations, they avoid issues with incorrect email addresses and spam filtering. If the recruited respondent did not have a smartphone, or preferred email, survey links were sent via email. Of the respondents who completed the CATI screener, 91 percent were recruited via SMS, and 9 percent were recruited by email. Of those recruited to the online survey by SMS, 51.7% completed the online survey. Among those sent an email invitation, the completion rate of the online survey was 78.2%.
To increase the response rate, inbound calling was allowed and directed to interviewers trained on the survey. If the potential respondent called from the phone that was initially dialled by someone in the call centre, the calling record was automatically displayed to an interviewer. In 2021, there were almost 13,000 inbound calls, and just under 2,300 respondents were recruited on an inbound call.
Invite reminders were sent 3 days and 6 days after the initial invitation. A third SMS/email reminder was sent to those flagged as being under 25 years of age an additional 3 days later, in an attempt to boost response rates. Once SMS/email reminders had been sent, Advanis also conducted telephone reminders at least 3 days after the last reminder to confirm the invite had been received, and to correct email addresses if necessary. During these calls (only made once), voicemail messages were left reminding the respondents that the survey was still open, and a final invitation was triggered automatically.
The average survey length for those who used cannabis in the past 12 months was 26 minutes, and it was 13 minutes on average for those who did not use cannabis in the past 12 months. We need to keep in mind that, during an online survey, the time elapsed doesn't necessarily align perfectly with survey duration since respondents may not always complete the survey all at once. As for the duration of the recruitment interviews, the average length was just over 2 minutes.
The pretest was conducted on April 7th, 2021 to April 8th, 2021 in both English and French. During this pretest, we recruited 85 people by phone, 56 in English and 29 in French. This translated into 20 completed online surveys, 10 in English and 10 in French. The validation of the data was completed the morning of April 8th. This validation included respondents who had used cannabis in the past 12 months, as well as those who had not, to ensure that all questions were tested. In reviewing the pretest data, it was suggested to add a level to question ix (main activity last week) of "temporarily not working due to COVID-19 pandemic restrictions". This change was implemented on April 8th. Since changes to the survey were minor, all pretest cases are included in the final analysis. The data collection period was from April 7th to June 28th, 2021.
Advanis utilizes technology to maximize quality control in survey programming. Having developed a proprietary survey engine tool, Advanis professionals are able to design and program a survey in a browser-based environment, eliminating the need to involve a programmer who is less familiar with the survey subject matter. Below are the steps followed to ensure the quality of the survey:
The CATI recruit script was programmed on Advanis' proprietary CATI platform with no unforeseen challenges. Advanis was able to leverage its experience with the survey programming and the reminder process to achieve high quality standards.
Advanis implemented the following to ensure the highest quality data collection:
To ensure high interview quality, our interviewers are trained to use various interviewing techniques. As well as maintaining a professional attitude, our interviewers must also be convincing, read word-for-word, take notes, probe deeper on semi-open and open questions, systematically confirm the information provided and listen to the respondents.
All Advanis Web surveys are hosted internally by Advanis, and we employ a rigorous and stringent set of data collection control mechanisms to ensure the highest quality for the data collected, including:
For all of the data collected, Advanis develops rules to check the validity of the data. These rules include items such as:
Advanis staff have used the SPSS Statistics Software for over 20 years and are very proficient users of the software. All data cleaning performed on projects are outlined in syntax files with intermediate data files saved throughout the process. This ensures that the original raw data file is never overwritten, and that if an error is discovered in our code, we can quickly and easily rerun the syntax to produce a new data file. Individuals developing code incorporate internal checks in their code (e.g., crosstabs) to ensure the syntax had the desired effect. In addition, all syntax is reviewed by another team member or technical specialist for accuracy.
The target audience for this project was Canadians who are 16 years and older. This survey included both those who had used cannabis and those who had not. A "person that uses cannabis" is someone who has used cannabis in the last 12 months. The expected incidence of cannabis use in the past 12 months in the general population is 15%, according to Health Canada data.
Key sub-population variables that required quotas were:
The sample consisted of a core sample of 10,000 Canadians aged 16 and older (those who use cannabis and those who do not). In the end, we gathered 10,736 responses (9,175 in English and 1,561 in French) in order to reach the quotas. Table 1 presents the results for the entire data collection versus the quota for the base sample.
Region | Minimum Sample Size | Target Sample Size | Results |
---|---|---|---|
NL | 400 | 400 | 453 |
PEI | 400 | 400 | 421 |
NS | 400 | 400 | 467 |
NB | 400 | 400 | 416 |
QC | 1,900 | 1,900 | 1,933 |
ON | 2,800 | 2,900 | 3,039 |
MB | 400 | 400 | 426 |
SK | 400 | 400 | 429 |
AB | 1,100 | 1,200 | 1,403 |
BC | 1,300 | 1,400 | 1,551 |
Territories | 180 | 200 | 198 |
Total | --- | 10,000 | 10,736 |
Age | Minimum Sample Size | Target Sample Size | Results |
16 to 19 years | 500 | 800 | 985 |
20 to 24 years | 800 | 1,000 | 1,228 |
25 years and older | 7,000 | 8,200 | 8,523 |
Sex | Minimum Sample Size | Target Sample Size | Results |
Male | 3,800 | 5,000 | 5,014 |
Female | 3,800 | 5,000 | 5,722 |
Overall, 10,736 web interviews were conducted during data collection. The weighting of the final file was based on three variables: region, age, and sex at birth. In 2021, the sex at birth question was required for all respondents so that all cases could be included in the analysis. The population sizes are based on the latest Statistics Canada census results published in the 2016 Census. Since the value for the 16 to 19 year age category was not available (only 15 to 19 is provided), we reduced the 15 to 19 year category by 1/5 of the size to reflect the best estimate of the number of 16 to 19 year olds. See section 4.2 for guidelines on the limitation of analysis with the weights.
Key | Region | Sex | Age | Weight |
---|---|---|---|---|
1M1 | AB | Male | 16 to 19 | 1735.02 |
1M2 | AB | Male | 20 to 24 | 2196.56 |
1M3 | AB | Male | 25 to 29 | 3198.27 |
1M4 | AB | Male | 30 to 34 | 3723.33 |
1M5 | AB | Male | 35 to 39 | 1969.87 |
1M6 | AB | Male | 40 to 44 | 1827.56 |
1M7 | AB | Male | 45 to 49 | 1886.88 |
1M8 | AB | Male | 50 to 54 | 2633.43 |
1M9 | AB | Male | 55 to 59 | 2474.38 |
1M10 | AB | Male | 60 to 64 | 2224.31 |
1M11 | AB | Male | 65 plus | 2860.31 |
1F1 | AB | Female | 16 to 19 | 1389.97 |
1F2 | AB | Female | 20 to 24 | 2166.86 |
1F3 | AB | Female | 25 to 29 | 2909.91 |
1F4 | AB | Female | 30 to 34 | 2509.47 |
1F5 | AB | Female | 35 to 39 | 2024.73 |
1F6 | AB | Female | 40 to 44 | 1631.29 |
1F7 | AB | Female | 45 to 49 | 2717.96 |
1F8 | AB | Female | 50 to 54 | 2220.31 |
1F9 | AB | Female | 55 to 59 | 2490.36 |
1F10 | AB | Female | 60 to 64 | 2211.57 |
1F11 | AB | Female | 65 plus | 2768.35 |
2M1 | BC | Male | 16 to 19 | 1182.22 |
2M2 | BC | Male | 20 to 24 | 1822.41 |
2M3 | BC | Male | 25 to 29 | 3093.67 |
2M4 | BC | Male | 30 to 34 | 3163.88 |
2M5 | BC | Male | 35 to 39 | 1683.12 |
2M6 | BC | Male | 40 to 44 | 2896.53 |
2M7 | BC | Male | 45 to 49 | 2546.31 |
2M8 | BC | Male | 50 to 54 | 3308.94 |
2M9 | BC | Male | 55 to 59 | 3642.77 |
2M10 | BC | Male | 60 to 64 | 2607.42 |
2M11 | BC | Male | 65 plus | 2887.30 |
2F1 | BC | Female | 16 to 19 | 1652.20 |
2F2 | BC | Female | 20 to 24 | 1686.08 |
2F3 | BC | Female | 25 to 29 | 2856.79 |
2F4 | BC | Female | 30 to 34 | 2441.69 |
2F5 | BC | Female | 35 to 39 | 2595.26 |
2F6 | BC | Female | 40 to 44 | 2944.42 |
2F7 | BC | Female | 45 to 49 | 2420.80 |
2F8 | BC | Female | 50 to 54 | 2250.68 |
2F9 | BC | Female | 55 to 59 | 2742.09 |
2F10 | BC | Female | 60 to 64 | 2122.09 |
2F11 | BC | Female | 65 plus | 3686.38 |
3M1 | MB | Male | 16 to 19 | 2431.43 |
3M2 | MB | Male | 20 to 24 | 4042.27 |
3M3 | MB | Male | 25 to 29 | 1815.42 |
3M4 | MB | Male | 30 to 34 | 2814.00 |
3M5 | MB | Male | 35 to 39 | 2099.47 |
3M6 | MB | Male | 40 to 44 | 1797.05 |
3M7 | MB | Male | 45 to 49 | 2064.21 |
3M8 | MB | Male | 50 to 54 | 1934.13 |
3M9 | MB | Male | 55 to 59 | 1814.58 |
3M10 | MB | Male | 60 to 64 | 3148.33 |
3M11 | MB | Male | 65 plus | 3179.46 |
3F1 | MB | Female | 16 to 19 | 1679.58 |
3F2 | MB | Female | 20 to 24 | 2643.75 |
3F3 | MB | Female | 25 to 29 | 3080.36 |
3F4 | MB | Female | 30 to 34 | 2046.67 |
3F5 | MB | Female | 35 to 39 | 1329.52 |
3F6 | MB | Female | 40 to 44 | 1657.92 |
3F7 | MB | Female | 45 to 49 | 2360.59 |
3F8 | MB | Female | 50 to 54 | 3023.67 |
3F9 | MB | Female | 55 to 59 | 3684.58 |
3F10 | MB | Female | 60 to 64 | 2808.93 |
3F11 | MB | Female | 65 plus | 3435.78 |
4M1 | NB | Male | 16 to 19 | 983.53 |
4M2 | NB | Male | 20 to 24 | 1329.69 |
4M3 | NB | Male | 25 to 29 | 2820.71 |
4M4 | NB | Male | 30 to 34 | 1438.57 |
4M5 | NB | Male | 35 to 39 | 1028.10 |
4M6 | NB | Male | 40 to 44 | 980.00 |
4M7 | NB | Male | 45 to 49 | 1679.67 |
4M8 | NB | Male | 50 to 54 | 1489.75 |
4M9 | NB | Male | 55 to 59 | 1438.57 |
4M10 | NB | Male | 60 to 64 | 2011.79 |
4M11 | NB | Male | 65 plus | 2446.43 |
4F1 | NB | Female | 16 to 19 | 1212.31 |
4F2 | NB | Female | 20 to 24 | 1680.42 |
4F3 | NB | Female | 25 to 29 | 1218.75 |
4F4 | NB | Female | 30 to 34 | 1186.94 |
4F5 | NB | Female | 35 to 39 | 1757.69 |
4F6 | NB | Female | 40 to 44 | 996.20 |
4F7 | NB | Female | 45 to 49 | 815.78 |
4F8 | NB | Female | 50 to 54 | 1563.25 |
4F9 | NB | Female | 55 to 59 | 1313.75 |
4F10 | NB | Female | 60 to 64 | 1245.63 |
4F11 | NB | Female | 65 plus | 3649.32 |
5M1 | NL | Male | 16 to 19 | 860.31 |
5M2 | NL | Male | 20 to 24 | 732.63 |
5M3 | NL | Male | 25 to 29 | 1281.36 |
5M4 | NL | Male | 30 to 34 | 1289.55 |
5M5 | NL | Male | 35 to 39 | 808.61 |
5M6 | NL | Male | 40 to 44 | 1116.33 |
5M7 | NL | Male | 45 to 49 | 749.60 |
5M8 | NL | Male | 50 to 54 | 1036.50 |
5M9 | NL | Male | 55 to 59 | 1314.69 |
5M10 | NL | Male | 60 to 64 | 822.80 |
5M11 | NL | Male | 65 plus | 1684.64 |
5F1 | NL | Female | 16 to 19 | 708.00 |
5F2 | NL | Female | 20 to 24 | 1723.13 |
5F3 | NL | Female | 25 to 29 | 1179.17 |
5F4 | NL | Female | 30 to 34 | 761.00 |
5F5 | NL | Female | 35 to 39 | 578.04 |
5F6 | NL | Female | 40 to 44 | 710.40 |
5F7 | NL | Female | 45 to 49 | 603.64 |
5F8 | NL | Female | 50 to 54 | 781.79 |
5F9 | NL | Female | 55 to 59 | 847.88 |
5F10 | NL | Female | 60 to 64 | 794.81 |
5F11 | NL | Female | 65 plus | 1795.17 |
6M1 | NS | Male | 16 to 19 | 954.18 |
6M2 | NS | Male | 20 to 24 | 1340.24 |
6M3 | NS | Male | 25 to 29 | 2435.45 |
6M4 | NS | Male | 30 to 34 | 1570.63 |
6M5 | NS | Male | 35 to 39 | 1535.31 |
6M6 | NS | Male | 40 to 44 | 1513.61 |
6M7 | NS | Male | 45 to 49 | 1857.19 |
6M8 | NS | Male | 50 to 54 | 2034.17 |
6M9 | NS | Male | 55 to 59 | 1605.43 |
6M10 | NS | Male | 60 to 64 | 2108.44 |
6M11 | NS | Male | 65 plus | 3089.44 |
6F1 | NS | Female | 16 to 19 | 1111.78 |
6F2 | NS | Female | 20 to 24 | 1273.18 |
6F3 | NS | Female | 25 to 29 | 1923.93 |
6F4 | NS | Female | 30 to 34 | 1266.67 |
6F5 | NS | Female | 35 to 39 | 946.55 |
6F6 | NS | Female | 40 to 44 | 1027.76 |
6F7 | NS | Female | 45 to 49 | 1109.31 |
6F8 | NS | Female | 50 to 54 | 1346.90 |
6F9 | NS | Female | 55 to 59 | 1522.31 |
6F10 | NS | Female | 60 to 64 | 1811.25 |
6F11 | NS | Female | 65 plus | 3861.92 |
7M1 | ON | Male | 16 to 19 | 2020.51 |
7M2 | ON | Male | 20 to 24 | 2791.59 |
7M3 | ON | Male | 25 to 29 | 4545.26 |
7M4 | ON | Male | 30 to 34 | 3969.81 |
7M5 | ON | Male | 35 to 39 | 3597.28 |
7M6 | ON | Male | 40 to 44 | 4404.89 |
7M7 | ON | Male | 45 to 49 | 3432.61 |
7M8 | ON | Male | 50 to 54 | 4788.61 |
7M9 | ON | Male | 55 to 59 | 3444.86 |
7M10 | ON | Male | 60 to 64 | 3331.97 |
7M11 | ON | Male | 65 plus | 5155.61 |
7F1 | ON | Female | 16 to 19 | 1847.67 |
7F2 | ON | Female | 20 to 24 | 1819.04 |
7F3 | ON | Female | 25 to 29 | 5277.17 |
7F4 | ON | Female | 30 to 34 | 4576.96 |
7F5 | ON | Female | 35 to 39 | 3461.26 |
7F6 | ON | Female | 40 to 44 | 3215.67 |
7F7 | ON | Female | 45 to 49 | 3641.20 |
7F8 | ON | Female | 50 to 54 | 4608.29 |
7F9 | ON | Female | 55 to 59 | 3473.80 |
7F10 | ON | Female | 60 to 64 | 3461.77 |
7F11 | ON | Female | 65 plus | 5618.18 |
8M1 | PE | Male | 16 to 19 | 295.33 |
8M2 | PE | Male | 20 to 24 | 439.00 |
8M3 | PE | Male | 25 to 29 | 285.00 |
8M4 | PE | Male | 30 to 34 | 311.25 |
8M5 | PE | Male | 35 to 39 | 242.81 |
8M6 | PE | Male | 40 to 44 | 423.50 |
8M7 | PE | Male | 45 to 49 | 332.14 |
8M8 | PE | Male | 50 to 54 | 543.00 |
8M9 | PE | Male | 55 to 59 | 318.82 |
8M10 | PE | Male | 60 to 64 | 325.63 |
8M11 | PE | Male | 65 plus | 395.00 |
8F1 | PE | Female | 16 to 19 | 306.55 |
8F2 | PE | Female | 20 to 24 | 384.55 |
8F3 | PE | Female | 25 to 29 | 207.89 |
8F4 | PE | Female | 30 to 34 | 201.25 |
8F5 | PE | Female | 35 to 39 | 148.10 |
8F6 | PE | Female | 40 to 44 | 163.75 |
8F7 | PE | Female | 45 to 49 | 175.36 |
8F8 | PE | Female | 50 to 54 | 277.38 |
8F9 | PE | Female | 55 to 59 | 184.84 |
8F10 | PE | Female | 60 to 64 | 238.04 |
8F11 | PE | Female | 65 plus | 407.43 |
9M1 | QC | Male | 16 to 19 | 2218.43 |
9M2 | QC | Male | 20 to 24 | 1530.91 |
9M3 | QC | Male | 25 to 29 | 4593.06 |
9M4 | QC | Male | 30 to 34 | 4931.44 |
9M5 | QC | Male | 35 to 39 | 4501.56 |
9M6 | QC | Male | 40 to 44 | 3025.00 |
9M7 | QC | Male | 45 to 49 | 3472.07 |
9M8 | QC | Male | 50 to 54 | 5943.56 |
9M9 | QC | Male | 55 to 59 | 5067.58 |
9M10 | QC | Male | 60 to 64 | 5020.73 |
9M11 | QC | Male | 65 plus | 5399.88 |
9F1 | QC | Female | 16 to 19 | 1774.78 |
9F2 | QC | Female | 20 to 24 | 1337.86 |
9F3 | QC | Female | 25 to 29 | 4667.55 |
9F4 | QC | Female | 30 to 34 | 3866.64 |
9F5 | QC | Female | 35 to 39 | 2999.40 |
9F6 | QC | Female | 40 to 44 | 2103.50 |
9F7 | QC | Female | 45 to 49 | 2910.28 |
9F8 | QC | Female | 50 to 54 | 3267.00 |
9F9 | QC | Female | 55 to 59 | 3503.10 |
9F10 | QC | Female | 60 to 64 | 4093.29 |
9F11 | QC | Female | 65 plus | 7371.47 |
10M1 | SK | Male | 16 to 19 | 2774.40 |
10M2 | SK | Male | 20 to 24 | 2121.76 |
10M3 | SK | Male | 25 to 29 | 2455.63 |
10M4 | SK | Male | 30 to 34 | 2271.18 |
10M5 | SK | Male | 35 to 39 | 1562.61 |
10M6 | SK | Male | 40 to 44 | 1354.58 |
10M7 | SK | Male | 45 to 49 | 2648.33 |
10M8 | SK | Male | 50 to 54 | 2863.85 |
10M9 | SK | Male | 55 to 59 | 2538.00 |
10M10 | SK | Male | 60 to 64 | 2262.33 |
10M11 | SK | Male | 65 plus | 2033.29 |
10F1 | SK | Female | 16 to 19 | 2029.54 |
10F2 | SK | Female | 20 to 24 | 1888.33 |
10F3 | SK | Female | 25 to 29 | 3823.50 |
10F4 | SK | Female | 30 to 34 | 1945.75 |
10F5 | SK | Female | 35 to 39 | 1550.00 |
10F6 | SK | Female | 40 to 44 | 954.12 |
10F7 | SK | Female | 45 to 49 | 1766.39 |
10F8 | SK | Female | 50 to 54 | 2111.94 |
10F9 | SK | Female | 55 to 59 | 1412.22 |
10F10 | SK | Female | 60 to 64 | 1477.61 |
10F11 | SK | Female | 65 plus | 3726.40 |
11M1 | Territories | Male | 16 to 19 | 320.40 |
11M2 | Territories | Male | 20 to 24 | 700.00 |
11M3 | Territories | Male | 25 to 29 | 2307.50 |
11M4 | Territories | Male | 30 to 34 | 446.00 |
11M5 | Territories | Male | 35 to 39 | 364.09 |
11M6 | Territories | Male | 40 to 44 | 300.00 |
11M7 | Territories | Male | 45 to 49 | 626.67 |
11M8 | Territories | Male | 50 to 54 | 661.67 |
11M9 | Territories | Male | 55 to 59 | 374.00 |
11M10 | Territories | Male | 60 to 64 | 268.18 |
11M11 | Territories | Male | 65 plus | 356.92 |
11F1 | Territories | Female | 16 to 19 | 232.62 |
11F2 | Territories | Female | 20 to 24 | 1290.00 |
11F3 | Territories | Female | 25 to 29 | 1531.67 |
11F4 | Territories | Female | 30 to 34 | 386.25 |
11F5 | Territories | Female | 35 to 39 | 523.13 |
11F6 | Territories | Female | 40 to 44 | 315.83 |
11F7 | Territories | Female | 45 to 49 | 305.00 |
11F8 | Territories | Female | 50 to 54 | 439.44 |
11F9 | Territories | Female | 55 to 59 | 268.85 |
11F10 | Territories | Female | 60 to 64 | 442.50 |
11F11 | Territories | Female | 65 plus | 420.00 |
The sample method used in a survey can have an effect in the precision of survey estimates when it is not possible to perform simple random sampling (SRS) with a 100% response rate. This effect is known as the design effect, a constant that can be applied to survey estimators to approximate those obtained under SRS4.
The following table provides the design effect for each region as well as for the entire country. This table also shows the size of the "effective" sample size, an estimate of the sample size that would have been required under SRS to achieve the same level of precision.
The difference in effective sample size between the sum of all regions and Canada as a whole is due to quotas being used to obtain a minimum of responses for each region instead of proportional sampling.
Province | Mean | N | Standard deviation | Design effect | Effective sample size | Margin of error |
---|---|---|---|---|---|---|
Alberta | 2309.3435 | 1403 | 518.2294 | 1.05035784 | 1336 | 2.7% |
British Columbia | 2517.6331 | 1551 | 683.1898 | 1.07363729 | 1445 | 2.6% |
Manitoba | 2389.8169 | 426 | 719.8110 | 1.09072098 | 391 | 5.0% |
New Brunswick | 1510.7692 | 416 | 673.9100 | 1.19897915 | 347 | 5.3% |
Newfoundland and Labrador | 970.9029 | 453 | 371.1641 | 1.14614381 | 395 | 4.9% |
Nova Scotia | 1669.2270 | 467 | 746.9094 | 1.20021892 | 389 | 5.0% |
Ontario | 3645.3343 | 3039 | 1143.8896 | 1.09846763 | 2767 | 1.9% |
Prince Edward Island | 281.4751 | 421 | 99.7403 | 1.12556298 | 374 | 5.1% |
Quebec | 3489.4542 | 1933 | 1653.7110 | 1.22459714 | 1578 | 2.5% |
Saskatchewan | 2025.9744 | 429 | 703.4778 | 1.12056824 | 383 | 5.0% |
Territories (NT, NU, YT) | 430.3434 | 198 | 284.5110 | 1.43708702 | 138 | 8.3% |
Canada | 2692.5192 | 10736 | 1420.6044 | 1.278374 | 8398 | 1.1% |
After the data collection was completed, data cleaning was performed to ensure high quality results. As was done in the 2020 survey, questions were made voluntary (not required) instead of adding an opt-out option. This was to allow respondents to advance past any questions they did not wish to answer (with the exception of age and sex at birth, which were required). During data cleaning, respondents who refused to provide an answer were recoded to "Prefer not to answer".
The next step was to perform any necessary data coding. A detailed scale was used to describe quantities across the survey. Once data collection was completed, these scales were transformed into metric questions for ease of analysis. The metric question type simplifies the analysis by easily providing measures of mean, median, etc. For this recoding of scales into a metric value, the recoding used the same logic as in the 2020 Canadian Cannabis Survey, for consistency and comparability of results. The scale used was the same as in the previous phases of the project. The recode scale used for this was provided by Health Canada.
A review of open-ended responses was also performed as part of the data cleaning. Any "other" responses were recoded into existing categories when appropriate. A coding guide was created for answers that had sufficient numbers of mentions to be added in as a new response level. Specific verbatim themes that did not have a sufficient number of mentions were left in the "other" category. Based on this review, levels were added for survey questions based on the "other, please specify" responses. In Q23b and Q23c, where respondents were asked about the changes in cannabis use due to COVID-19, additional levels were added after reviewing the data. For M5, similar to previous cycles, a level of "pain due to injury, illness or migraines" was added to decrease the proportion of the "other" response category.
When doing an analysis, it is important to align the analysis plan with the weighting scheme. The weights adjust the data to better reflect the population based on parameters that have been chosen to maximize the level of detail without creating distortions due to extreme weights (an extreme weight will occur when a population group is represented by a proportionally smaller subset of respondents compared to other population groups, thus introducing an important risk of bias due to their specific profile).
For this survey, the basic sociodemographic information that should be used in the analysis of results are:
Using age groupings other than the ones described above for these sociodemographic categories could potentially produce distorted data. As these results would be inaccurate based on how the weights were calculated, we strongly advise not to report any results that are not aligned with these specified categories.
In the provided data file, the variable to be used to weight the data is called "weight". In this case, it was decided to project to the total population, around 28 million Canadian residents (per the 2016 Statistics Canada Census).
Any results with an unweighted cell size of less than 30 respondents should not be reported on, due to statistical robustness. The reason for suppressing results with small cell sizes is due to the increased coefficient of variation and, hence, there are larger confidence intervals around results with smaller bases.
For all estimates based on cell sizes of 30 or more, the following guidelines for data suppression related to coefficients of variation (CV) should be used when reporting results:
CV5 range | Estimate Stability |
0 – 16.5 | Acceptable, the estimate stable |
16.6 – 33.3 | Marginal, the estimate has moderate sampling variability and should be interpreted with caution |
>33.3 | Unacceptable, the estimate is unstable and should be suppressed |
TOTAL | % | |
---|---|---|
Generated | 129902 | 100.0% |
Used | 129902 | 100.0% |
No service | 14285 | 11.0% |
Not residential/business | 1835 | 1.4% |
Line problems | 1327 | 1.0% |
Fax | 653 | 0.5% |
Wrong number | 111 | 0.1% |
Invalid6 | 18211 | 14.0% |
Potentially Eligible | 111691 | 86.0% |
U. No answer | 18986 | 17.0% |
U. Busy | 405 | 0.4% |
U. Answering machine/voicemail | 22939 | 20.5% |
U. Unresolved7 | 42330 | 32.6% |
IS. Language barrier | 890 | 0.8% |
IS. Illness/incapacity | 280 | 0.3% |
IS. Household refusals | 17915 | 16.0% |
IS. Respondent refusal | 24567 | 22.0% |
IS. Appointments | 2102 | 1.9% |
IS. In-Scope Non-Responding8 | 45754 | 35.2% |
R. Non eligible | 3798 | 3.4% |
R. Quota Blocked | 0 | 0.0% |
R. Completed | 19809 | 17.7% |
R. Responding Units9 | 23607 | 21.1% |
% REFUSAL10 | 38.0% |
% COMPLETED11 | 17.7% |
COOPERATION RATE12 | 34.0% |
RESPONSE RATE13 | 21.1% |
Political neutrality certification
I hereby certify as Senior Officer of Advanis that the deliverables fully comply with the Government of Canada political neutrality requirements outlined in the Communications Policy of the Government of Canada and Procedures for Planning and Contracting Public Opinion Research.
Specifically, the deliverables do not include information on electoral voting intentions, political party preferences, standings with the electorate, or ratings of the performance of a political party or its leaders.
Signed:
Nicolas Toutant, Vice-President, Research and Evaluation
Government of Canada
Generated on 2021-05-05 at 05:36:46 MT
Languages: English, French
Section Introduction 1
Intro1, i, ii, iii, iv, v, vi, vii, viii, ix, ixa, ixb, x, xa, xi, xia, xii, xiii, xiv, xv
Health Canada is conducting this research survey on knowledge about and use of cannabis. Advanis has been hired to administer the survey. Si vous préférez répondre au sondage en français, veuillez cliquer sur le bouton FRANÇAIS ci-dessus.
The survey takes between 5 and 20 minutes to complete and is voluntary and completely confidential. Your answers will remain anonymous.
If you wish to verify the authenticity of this survey please email: hc.odss-bssd.sc@canada.ca and specify you are asking about the Canadian Cannabis Survey.
The survey automatically moves to the next question when possible, however in some cases you need to press the right arrow button at the bottom of the screen to move to the next question. This button will not appear until you have answered the question.
To change previous answers you can press the left arrow button at the bottom of the screen. Some questions provide further information if you press the following symbol:
If you need to stop the survey at any point you can return at a later time and the survey will continue where you left off.
For help you can contact 1-888-944-9212.
© 2021 Advanis Privacy Policy CRIC Pledge
i
What is your age?
An answer is required. To expand the category select the “+” and make your selection within the group.
ii
Is there anyone other than yourself living in your home that is under the age of 18?
iii Show if ii Children under 18 at home
What age group(s) does the child or children fall into?
Select all that apply
iv
What was your sex at birth?
v
What is your gender?
Refers to current gender which may be different from sex assigned at birth and may be different from what is indicated on legal documents.
vi
How would you describe your sexual orientation? Is it:
vii
Do you live in a rural or urban area?
viii
In which province or territory do you currently live?
ix
Last week, was your main activity...?
ixa Show if is 4 Going to school
Are you currently attending one of the following educational institutions?
ixb Show if ix 1 Working at paid job
Does your job include any of the following hazardous or safety-sensitive tasks at least once a week?
x
We know that people of different races do not have significantly different genetics. But our race still has important consequences, including how we are treated by different individuals and institutions. Which race category best describes you?
Select all that apply
xa Show if x 3 Indigenous
Which Indigenous group(s) do you identify as?
Select all that apply
xi
Were you born in Canada?
xia Show if xi No
How many years have you lived in Canada?
Minimum: 0.0, Maximum: 100.0
__________ years
Maximum is custom programmed to be respondent's age.
xii
In general, how is your physical health?
xiii
In general, how is your mental health?
xiv
What is the highest certificate, diploma or degree that you have completed?
xv
What is your best estimate of your total household income received by all household members, from all sources, before taxes and deductions, during the year ending December 31, 2020?
Section Non-Medical
MainInt, Q1, Q2, Q3, Q4a, Q4b, Q4c, Q4d, Q5a, Q5b, Q6a, Q6b, Q6c, Q7, Q8, Q9, Q10, Q11, Q12a, Q12b, Q12c, Q13, Q14, Q15, Q16, Q17, Q18a, Q18b, Q19, Q20, Q21, Q22, Q23a, Q23b, Q23c, Q23d, Q24, Q25, Q26a, Q26b, Q26c, Q27, Q28, Q29a, Q29b, Q29c, Q29d, Q29e, Q29f, Q29g, Q29h, Q29i, Q30, Q31a, Q31b, Q31c, Q31d, Q31e, Q31f, Q31g, Q31h, Q31i, Q32, Q33, Q34a, Q34b, Q34c, Q34d, Q35a, Q35b, Q35c, Q36, Q36other, Q37, Q38, Q39, Q40, Q41, Q42, Q43a, Q43b, Q44, Q45, Q46a1, Q46b1, Q46a2, Q46b2, Q46a3, Q46b3, Q46a4, Q46b4, Q46a5, Q46b5, Q46a6, Q46b6, Q46a7, Q46b7, Q46a8, Q46b8, Q46a9, Q46b9, Q47, Q48, Q49, Q50, Q51, Q52a, Q52b, Q53, Q54a, Q54b, Q55, Q56, Q56b, Q56c, Q57, Q57b, Q57c, Q58, Q58b, Q59, Q59b, Q60, Q61, Q62, Q63, Q64, Q65, Q66, Q67, Q68, Q69, Q70, Q71, Q72, Q73, Q74, Q75, Q76, Q77, Q78
In this survey when we use the term cannabis, this includes marijuana (e.g., weed, pot), hashish, hash oil or any other products made from the cannabis plant, but not synthetic cannabinoids.
When we ask about use, this includes using cannabis in its dry form or when mixed or processed into another product such as an edible, an extract, a concentrate, including hashish, a liquid, or other product.
By non-medical purposes we mean recreational (e.g., for enjoyment, pleasure, amusement), socially, for spiritual, lifestyle and other similar non-medical uses.
By medical purposes we mean used to treat a disease/disorder or to improve symptoms associated with a disease/disorder.
Q1
How socially acceptable do you think it is for a person to use the following substances occasionally?
Q2
How socially acceptable do you think it is for a person to use the following substances regularly?
Q3
How much do you think people risk harming themselves when they do each of the following activities?
Q4a
In the past 12 months, have you seen health warning messages on cannabis products/packages or on Health Canada's website?
Q4b Show if Q4a Yes 1 2 3 to seeing health warning messages
Was the information you saw in the health warning messages credible/believable?
Q4c Show if Q4a Yes 1 2 3 to seeing health warning messages
Have the health warning messages increased your knowledge of the potential harms related to cannabis use?
Q4d Show if Q4a No to seeing health warning message
Do you feel you sufficiently know the potential harms related to cannabis without seeing the health warning messages?
Q5a
In the past 12 months, have you seen the cannabis consumer information sheet produced by the Government of Canada?
Select all that apply
Q5b Show if Q5a 1 2 3 Yes to seeing the consumer information sheet
Has the consumer information sheet increased your knowledge of the harms related to cannabis use?
Q6a
In the past 12 months, have you seen/heard education campaigns, public health or safety messages about cannabis in any of the following places?
Select all that apply
Q6b Show if Q6a Yes 1 to 14
Which of the following types of themes were the education campaigns, public health or safety messages relevant to?
Select all that apply
Q6c Show if Q6a Yes 1 to 14
Was the information you saw in the education campaigns, public health or safety messages credible/believable?
Q7
Do you agree or disagree with the following statement:
I have access to enough trustworthy information about the health risks of cannabis use to make informed decisions.
Q8
Are you aware of the 'Lower-Risk Cannabis Use Guidelines' (LRCUG)?
Q9
Based on what you know or believe…
Q10
In the past 30 days, were you exposed to second-hand cannabis smoke or vapour at the following locations?
Q11
In the past 12 months, has anyone, including yourself, grown cannabis in your home/residence or on your property?
Q12a Show if Q11 Yes
In the past 12 months, how many plants were grown outside on your property?
Minimum: 0, Maximum: 25
Q12b Show if Q11 Yes
In the past 12 months, how many plants were grown inside your home?
Minimum: 0, Maximum: 25
Q12c Show if Q11 Yes
How many cannabis plants are currently grown in your home/residence or on your property?
Minimum: 0, Maximum: 25
Q13
In the past 12 months, has anyone, including yourself, prepared cannabis edibles/drinks in your home/residence?
Q14
In your opinion, does using cannabis for non-medical purposes impair one's ability to drive or operate a motor vehicle?
Q15
As far as you know, when is it safe for someone to drive a motor vehicle after inhaling (smoking/vaping) cannabis for non-medical purposes?
Q16
As far as you know, when is it safe for someone to drive a motor vehicle after ingesting (eating/drinking) cannabis for non-medical purposes?
Q17
How likely do you think it is that a person will be caught by police if they drive while under the influence of the following substances?
Q18a
Have you ever been a passenger in a motor vehicle (e.g., car, snowmobile, motor boat or all-terrain vehicle (ATV)) driven by someone who had used cannabis for non-medical purposes within 2 hours before driving?
Q18b Show if Q18a Yes passenger in vehicle
When did this last happen?
Q19
During your lifetime have you ever used cannabis for non-medical *?* purposes?
*?* By non-medical purposes we mean recreational (e.g., for enjoyment, pleasure, amusement), socially, for spiritual, lifestyle and other similar non-medical uses.
Q20Show if Q19 Used nonmedical in lifetime
How old were you when you first tried or started using cannabis for non-medical purposes?
Q21
In the past 12 months, have you used cannabis for medical purposes (used to treat disease/disorder or improve symptoms)?
Q22 Show if Q19 Used nonmedical in lifetime
In the past 12 months, have you used cannabis for non-medical purposes?
Q23a Show if Q22 NonMedical user past 12 months
Has the amount/quantity of cannabis you use for non-medical purposes changed since March 2020 with the onset of the COVID-19 pandemic? *?*
*?* novel coronavirus outbreak.
Q23b Show if Q23a use more
Why did your cannabis use for non-medical purposes change due to the COVID-19 pandemic? *?*
Select all that apply
*?* novel coronavirus outbreak.
Q23c Show if Q23a use less
Why did your cannabis use for non-medical purposes change due to the COVID-19 pandemic? *?*
Select all that apply
*?* novel coronavirus outbreak.
Q23d Show if Q22 NonMedical user past 12 months
Has the frequency of your cannabis use for non-medical purposes changed since March 2020 with the onset of the COVID-19 restrictions? *?*
*?* novel coronavirus outbreak.
Q24 Show if Q22 NonMedical user past 12 months
Are you more willing to publicly say whether you use cannabis for non-medical purposes now that cannabis is legal in Canada?
Q25 Show if Q22 NonMedical user past 12 months
In the past 12 months, how often did you typically use cannabis for non-medical purposes?
Q26a Show if Q22 NonMedical user past 12 months
In the past 12 months, did you use the following method to consume cannabis for non-medical purposes?
Select all that apply
Q26b Show if Q26a Vapourized with a portable 5 or non portable 4 device
What cannabis products did you use when vapourizing cannabis?
Select all that apply
Q26c Show if Q26a 5 Vapourized with portable device
What type of portable vaping device did you use when vapourizing cannabis?
Q27 Show if Q22 NonMedical user past 12 months
When choosing cannabis products for non-medical purposes, what levels of THC and CBD do you typically use?
Q28 Show if Q22 NonMedical user past 12 months
In the past 12 months, have you used the following cannabis products for non-medical purposes?
Select all that apply
Q29a Show if Q28 1 Used Dried flower past 12 months
When choosing cannabis products for non-medical purposes, what levels of THC and CBD do you typically use for:
Dried flower/leaf?
Please make a selection in each of the CBD and THC sections.
THC Levels
CBD Levels
Q29b Show if Q28 2 Used Hashish kief past 12 months
When choosing cannabis products for non-medical purposes, what levels of THC and CBD do you typically use for:
Hashish/kief?
Please make a selection in each of the CBD and THC sections.
THC Levels
CBD Levels
Q29c Show if Q28 3 Used Cannabis oil for oral use past 12 months
When choosing cannabis products for non-medical purposes, what levels of THC and CBD do you typically use for:
Cannabis oil for oral use - e.g., in dropper/syringe, softgel/capsules, spray bottle?
Please make a selection in each of the CBD and THC sections.
THC Levels
CBD Levels
Q29d Show if Q28 4 Used Cannabis vape pen past 12 months
When choosing cannabis products for non-medical purposes, what levels of THC and CBD do you typically use for:
Cannabis vape pens/cartridges?
Please make a selection in each of the CBD and THC sections.
THC Levels
CBD Levels
Q29e Show if Q28 5 Used Cannabis concentrate past 12 months
When choosing cannabis products for non-medical purposes, what levels of THC and CBD do you typically use for:
Cannabis concentrate/extracts - e.g., shatter/wax/budder/butane honey oil?
Please make a selection in each of the CBD and THC sections.
THC Levels
CBD Levels
Q29f Show if Q28 6 Used Cannabis edibles past 12 months
When choosing cannabis products for non-medical purposes, what levels of THC and CBD do you typically use for:
Cannabis edible food products - e.g., cookies, candy?
Please make a selection in each of the CBD and THC sections.
THC Levels
CBD Levels
Q29g Show if Q28 7 Used Cannabis beverages past 12 months
When choosing cannabis products for non-medical purposes, what levels of THC and CBD do you typically use for:
Cannabis beverages - e.g., sparkling water, tea, dissolvable powder?
Please make a selection in each of the CBD and THC sections.
THC Levels
CBD Levels
Q29h Show if Q28 8 Used Topicals past 12 months
When choosing cannabis products for non-medical purposes, what levels of THC and CBD do you typically use for:
Topicals - e.g., lotion, ointment, creams applied to skin?
Please make a selection in each of the CBD and THC sections.
THC Levels
CBD Levels
Q29i Show if Q28 9 Used Other past 12 months
When choosing cannabis products for non-medical purposes, what levels of THC and CBD do you typically use for:
Other: <<Q28.specify(9)>>?
Please make a selection in each of the CBD and THC sections.
THC Levels
CBD Levels
Q30 Show if Q22 NonMedical user past 12 months
In the past 12 months, how often have you used the following cannabis products for non-medical purposes?
Q31a Show if Q28 1 Used Dried flower past 12 months
On the days that you used:
Dried flower/leaf How much did you typically use in a day, for non-medical purposes?
Please select the amount closest to what you typically use
Q31b Show if Q28 2 Used Hashish kief past 12 months
On the days that you used:
Hashish/kief How much did you typically use in a day, for non-medical purposes?
Please select the amount closest to what you typically use
Q31c Show if Q28 3 Used Cannabis oil for oral use past 12 months
On the days that you used:
Cannabis oil for oral use - e.g., in dropper/syringe, softgel/capsules, spray bottle How much did you typically use in a day, for non-medical purposes?
Please select the amount closest to what you typically use
Q31d Show if Q28 4 Used Cannabis vape pen past 12 months
On the days that you used:
Cannabis vape pens/cartridges How much did you typically use in a day, for non-medical purposes?
Please select the amount closest to what you typically use
Q31e Show if Q28 5 Used Cannabis concentrate past 12 months
On the days that you used:
Cannabis concentrate/extracts - e.g., shatter/wax/budder/butane honey oil How much did you typically use in a day, for non-medical purposes?
Please select the amount closest to what you typically use
Q31f Show if Q28 6 Used Cannabis edibles past 12 months
On the days that you used:
Cannabis edible food products - e.g., cookies, candy How much did you typically use in a day, for non-medical purposes?
Please select the amount closest to what you typically use
Q31g Show if Q28 7 Used Cannabis beverages past 12 months
On the days that you used:
Cannabis beverages - e.g., sparkling water, tea, dissolvable powder How much did you typically use in a day, for non-medical purposes (including any liquid that the product is mixed with)?
Please select the amount closest to what you typically use
Q31h Show if Q28 8 Used Topicals past 12 months
On the days that you used:
Topicals - e.g., lotion, ointment, creams applied to skin How much did you typically use in a day, for non-medical purposes?
Please do not enter personally-identifying information.
Q31i Show if Q28 9 Used Other past 12 months
On the days that you used:
Other: <<Q28.specify(9)>> How much did you typically use in a day, for non-medical purposes?
Please do not enter personally-identifying information.
Q32 Show if Q22 NonMedical user past 12 months
In the past 12 months from whom did you usually buy or receive the cannabis you used for non-medical purposes?
Q33 Show if Q22 NonMedical user past 12 months
Do you feel that you have reasonable access to cannabis for non-medical purposes though a legal supplier?
Q34a Show if Q22 NonMedical user past 12 months
In the past 12 months, how often did you buy or receive any cannabis for non-medical purposes from a legal/licensed source?
Q34b Show if Q34a 1 2 3 or 4
What were these legal/licensed sources?
Select all that apply
Q34c Show if Q34b 3 From someone sharing with me
Did you pay the person(s) for the cannabis they shared with you?
Q34d Show if Q34a 1 2 3 or 4
How, if at all, has your access to cannabis for non-medical purposes from legal/licensed sources changed due to the COVID-19 pandemic? *?*
Select all that apply
*?* novel coronavirus outbreak.
Q35a Show if Q22 NonMedical user past 12 months
In the past 12 months, how often did you buy or receive any cannabis for non-medical purposes from an illegal/unlicensed source?
Q35b Show if Q35a 1 2 3 or 4
What were these illegal/unlicensed sources?
Select all that apply
Q35c Show if Q35a 1 2 3 or 4
How, if at all, has your access to cannabis for non-medical purposes from illegal/unlicensed sources changed due to the COVID-19 pandemic? *?*
Select all that apply
*?* novel coronavirus outbreak.
Q36 Show if Q22 NonMedical user past 12 months
Which factors most influence from whom you usually buy or receive the cannabis you use for non-medical purposes?
Please rank your top 3 choices. You may use the arrows to move a selection up or down, and the X to remove a selection.
Q36other Show if Q36 Other Selected in top 3
What is the other factor that influences from whom you usually buy or receive the cannabis you use for non-medical purposes?
Please do not enter personally-identifying information.
Q37 Show if Q22 NonMedical user past 12 months
In the past 12 months, how often have you intended to buy a cannabis product for non-medical purposes from a provincially regulated retailer but have found the product you wanted to buy was unavailable?
Q38 Show if Q22 NonMedical user past 12 months
How much do you typically spend on cannabis for non-medical purposes each month?
Minimum: 0.00, Maximum: 1000.00
__________ Enter estimated dollar amount
Q39 Show if Q22 NonMedical user past 12 months
In the past 30 days, have you used cannabis for non-medical purposes?
Q40 Show if Q39 NonMedical user past 30 days
In the past 30 days, on how many days did you use cannabis for non-medical purposes?
Minimum: 1.0, Maximum: 30.0
__________ Please enter the number of days
Q41 Show if Q39 NonMedical user past 30 days
In the past 30 days, on the days that you used cannabis for non-medical purposes, how many times (a time includes a period of continuous use) per day did you use on average?
Q42 Show if Q39 NonMedical user past 30 days
In the past 30 days, how many hours were you "stoned" or "high" on a typical day when you had been using cannabis for non-medical purposes?
Q43a Show if Q39 NonMedical user past 30 days
In the past 30 days, how much did you spend on cannabis for non-medical purposes obtained from a legal source?
Minimum: 0.0, Maximum: 1000.0
__________ Enter estimated dollar amount
Q43b Show if Q39 NonMedical user past 30 days
In the past 30 days, how much did you spend on cannabis for non-medical purposes obtained from an illegal source?
Minimum: 0.0, Maximum: 1000.0
__________ Enter estimated dollar amount
Q44 Show if Q39 NonMedical user past 30 days
In the past 30 days, which form(s) of cannabis have you bought or received for non-medical purposes?
Select all that apply
Q45 Show if Q39 NonMedical user past 30 days
In the past 30 days, how often have you bought or received cannabis in the following form(s) for non-medical purposes?
Q46a1 Show if Q44 1 Used Dried flower past 30 days
Typically, how much cannabis in the form:
Dried flower/leaf did you buy or receive each time for non-medical purposes?
Please select the amount closest to what you typically bought or received each time.
Q46b1 Show if Q44 1 Used Dried flower past 30 days
How much did you pay for this amount?
Minimum: 0.0, Maximum: 1000.0
__________ Enter dollar amount
Q46a2 Show if Q44 2 Used Hashish kief past 30 days
Typically, how much cannabis in the form:
Hashish/kief did you buy or receive each time for non-medical purposes?
Please select the amount closest to what you typically bought or received each time.
Q46b2 Show if Q44 2 Used Hashish kief past 30 days
How much did you pay for this amount?
Minimum: 0.0, Maximum: 1000.0
__________ Enter dollar amount
Q46a3 Show if Q44 3 Used Cannabis oil for oral past 30 days
Typically, how much cannabis in the form:
Cannabis oil for oral use - e.g., in dropper/syringe, softgel/capsules, spray bottle did you buy or receive each time for non-medical purposes?
Please select the amount closest to what you typically bought or received each time.
Q46b3 Show if Q44 3 Used Cannabis oil for oral past 30 days
How much did you pay for this amount?
Minimum: 0.0, Maximum: 1000.0
__________ Enter dollar amount
Q46a4 Show if Q44 4 Used Cannabis vape pen past 30 day
Typically, how much cannabis in the form:
Cannabis vape pens/cartridges did you buy or receive each time for non-medical purposes?
Please select the amount closest to what you typically bought or received each time.
Q46b4 Show if Q44 4 Used Cannabis vape pen past 30 day
How much did you pay for this amount?
Minimum: 0.0, Maximum: 1000.0
__________ Enter dollar amount
Q46a5 Show if Q44 5 Used Cannabis concentrate past 30 days
Typically, how much cannabis in the form:
Cannabis concentrate/extracts - e.g., shatter/wax/budder/butane honey oil did you buy or receive each time for non-medical purposes?
Please select the amount closest to what you typically bought or received each time.
Q46b5 Show if Q44 5 Used Cannabis concentrate past 30 days
How much did you pay for this amount?
Minimum: 0.0, Maximum: 1000.0
__________ Enter dollar amount
Q46a6 Show if Q44 6 Used Cannabis edibles past 30 days
Typically, how much cannabis in the form:
Cannabis edible food products - e.g., cookies, candy did you buy or receive each time for non-medical purposes?
Please select the amount closest to what you typically bought or received each time.
Q46b6 Show if Q44 6 Used Cannabis edibles past 30 days
How much did you pay for this amount?
Minimum: 0.0, Maximum: 1000.0
__________ Enter dollar amount
Q46a7 Show if Q44 7 Used Cannabis beverages past 30 days
Typically, how much cannabis in the form:
Cannabis beverages - e.g., sparkling water, tea, dissolvable powder did you buy or receive each time for non-medical purposes?
Please select the amount closest to what you typically bought or received each time.
Q46b7 Show if Q44 7 Used Cannabis beverages past 30 days
How much did you pay for this amount?
Minimum: 0.0, Maximum: 1000.0
__________ Enter dollar amount
Q46a8 Show if Q44 8 Used Topicals past 30 days
Typically, how much cannabis in the form:
Topicals - e.g., lotion, ointment, creams applied to skin did you buy or receive each time for non-medical purposes?
Please do not enter personally-identifying information.
Q46b8 Show if Q44 8 Used Topicals past 30 days
How much did you pay for this amount?
Minimum: 0.0, Maximum: 1000.0
__________ Enter dollar amount
Q46a9 Show if Q44 9 Used Other past 30 days
Typically, how much cannabis in the form:
Other: <<Q44.specify(9)>> did you buy or receive each time for non-medical purposes?
Please do not enter personally-identifying information.
Q46b9 Show if Q44 9 Used Other past 30 days
How much did you pay for this amount?
Minimum: 0.0, Maximum: 1000.0
__________ Enter dollar amount
Q47 Show if Q39 NonMedical user past 30 days
In the past 30 days, where have you used cannabis for non-medical purposes?
Select all that apply
Q48 Show if ix 3 Going to school AND Q22 NonMedical user past 12 months
In the past 12 months, how often did you use cannabis for non-medical purposes at school/college/university or within 2 hours before going to school/college/university?
Q49 Show if ix 3 Going to school AND Q22 NonMedical user past 12 months
In a typical month, how often are you absent from school/college/university because of your non-medical use of cannabis?
Q50 Show if Q22 NonMedical user past 12 months
In the past 12 months, how often did you use cannabis for non-medical purposes at work (including breaks) or within 2 hours before going to work?
Q51 Show if Q50 NOT Have not been employed past 12 months
In a typical month, how often are you absent from work (virtually or in person) because of your non-medical use of cannabis?
Q52a Show if Q22 NonMedical user past 12 months
Do you currently have any cannabis or cannabis product in or around your home?
Q52b Show if Q52a Yes cannabis in house
Where is the cannabis that is currently in or around your home being stored?
Select all that apply
Q53 Show if Q22 NonMedical user past 12 months
During the past 12 months, when you used cannabis, how often did you combine it with any of the following substances?
"Combine" means mixed or consumed at the same time.
Q54a Show if Q22 NonMedical user past 12 months
Were there any other substances that you used in combination (i.e., at the same time) with cannabis for non-medical purposes for the effect in the past 12 months?
Q54b Show if Q54a Yes other substance
And how often did you use <<Q54a.specify(1)>> in combination (i.e., at the same time) with cannabis for non-medical purposes for the effect?
Q55 Show if Q22 NonMedical user past 12 months
Since cannabis became legal for non-medical purposes, has your consumption of the following substances changed?
Q56 Show if Q22 NonMedical user past 12 months
Have you driven a motor vehicle (e.g., car, snowmobile, motor boat or all-terrain vehicle (ATV)) within 2 hours of smoking or vapourizing cannabis or a cannabis product for non-medical purposes?
Q56b Show if Q56 Yes driven within 2hrs of smoking vaping
When did this last happen?
Q56c Show if Q56 Yes AND Q56b within past 30 days
What type of cannabis product was it?
Q57 Show if Q22 NonMedical user past 12 months
Have you driven a motor vehicle (e.g., car, snowmobile, motor boat or all-terrain vehicle (ATV)) within 4 hours of ingesting a cannabis product (e.g., cannabis food/beverages, capsules) for non-medical purposes?
Q57b Show if Q57 Yes driven within 4hrs of ingesting
When did this last happen?
Q57c Show if Q57 Yes AND Q57b within past 30 days
What type of cannabis product was it?
Q58 Show if Q56 Yes driven 2hrs smoking vaping OR Q57 Yes driven 4hrs eating
Have you driven a motor vehicle (e.g., car, snowmobile, motor boat or all-terrain vehicle (ATV)) within 2 hours of using cannabis for non-medical purposes in combination with alcohol?
Q58b Show if Q58 Yes driven within 2hrs combined with alcohol
When did this last happen?
Q59 Show if Q56 Yes driven 2hrs smoking vaping OR Q57 Yes driven 4hrs eating
Have you driven a motor vehicle (e.g., car, snowmobile, motor boat or all-terrain vehicle (ATV)) within 2 hours of using cannabis or a cannabis product for non-medical purposes in combination with another drug other than alcohol or tobacco?
Q59b Show if Q59 Yes driven within 2hrs combined with another drug
When did this last happen?
Q60 Show if Q56 Yes driven 2hrs smoking vaping OR Q57 Yes driven 4hrs eating
Why did you drive a motor vehicle after using cannabis?
Select all that apply
Q61 Show if Q21 Medical OR Q22 NonMedical users past 12 month
In the past 12 months, have you, as the driver, ever had an interaction with police/law enforcement involving driving under the influence of cannabis?
Q62 Show if Q22 NonMedical user past 12 months
In the past 12 months, did you personally have an interaction with police/law enforcement involving your personal possession of cannabis for non-medical purposes?
Q63 Show if Q22 NonMedical user past 12 months
During the past 12 months, what type of effect did your cannabis use for non-medical purposes have on your:
Levels marked with * are randomized
Q64 Show if Q22 NonMedical user past 12 months
During the past 3 months, how often did you use cannabis for non-medical purposes?
Q65 Show if Q64 Used NonMedical past 3 months
During the past 3 months, how often have you had a strong desire or urge to use cannabis for non-medical purposes?
Q66 Show if Q64 Used NonMedical past 3 months
During the past 3 months, how often has your use of cannabis for non-medical purposes led to health, social, legal or financial problems?
Q67 Show if Q64 Used NonMedical past 3 months
During the past 3 months, how often have you failed to do what was normally expected of you because of your use of cannabis for non-medical purposes?
Q68 Show if Q64 Used NonMedical past 3 months
Has a friend or relative or anyone else ever expressed concern about your use of cannabis for non-medical purposes?
Q69 Show if Q64 Used NonMedical past 3 months
Have you ever tried and failed to control, cut down or stop using cannabis for non-medical purposes?
Q70 Show if Q19 Used nonmedical more than once in lifetime
During your lifetime, did you feel that you needed professional help (such as treatment or counseling) for your non-medical use of cannabis?
Q71 Show if Q19 Used nonmedical more than once in lifetime
Have you ever received professional help (such as treatment or counseling) for your non-medical use of cannabis?
Q72 Show if Is19 or older non ABQC OR 18 or older AB OR 21 or older QC AND Q22 Nonmedical user 12months
(if Is 19 plus AND non AB QC) In the past 12 months, have you used cannabis for non-medical purposes in front of persons that are under 19 years old?
(if Is 18 plus AND AB) In the past 12 months, have you used cannabis for non-medical purposes in front of persons that are under 18 years old?
(if Is 21 plus AND QC) In the past 12 months, have you used cannabis for non-medical purposes in front of persons that are under 21 years old?
Q73 Show if Is19 or older non ABQC OR 18 or older AB OR 21 or older QC AND Q22 Nonmedical user 12months
(if Is 19 plus AND non AB QC) In the past 12 months, have you shared cannabis for non-medical purposes with persons that are under 19 years old?
(if Is 18 plus AND AB) In the past 12 months, have you shared cannabis for non-medical purposes with persons that are under 18 years old?
(if Is 21 plus AND QC) In the past 12 months, have you shared cannabis for non-medical purposes with persons that are under 21 years old?
Q74 Show if Not legal age AND Q22 NonMedical user past 12 months
(if Is Under 19 Non AB QC) In the past 12 months, has someone 19 years of age or older shared cannabis for non-medical purposes with you?
(if Is Under 18 AB) In the past 12 months, has someone 18 years of age or older shared cannabis for non-medical purposes with you?
(if Is Under 21 QC) In the past 12 months, has someone 21 years of age or older shared cannabis for non-medical purposes with you?
Q75 Show if Female AND 16 to 50 years old
Have you given birth (including live and still births *?*) during the past 5 years?
*?* A still birth has a birth weight of 500 grams or more, or the duration of pregnancy is 20 weeks or longer.
Page BirthQuestions Show if Q19 Used nonmedical in lifetime
Q76 Show if Q75 Given birth past 5 years
After you learned that you were pregnant with your last child, did you use cannabis during the pregnancy?
Q77 Show if Q75 Given birth past 5 years
Was your last child breastfed or given your breast milk even for a short time?
Q78 Show if Q77 Breastfed
While you were breastfeeding your last child, did you use cannabis?
Section Medical_Use
Mcontinue, MInt, M1, M2, M3, M4, M5, M6, M7a, M7b, M8, M9, M9a, M9b, M10a, M10b, M10c, M11a, M11b, M12, M12a, M12b, M13, M14, M15a, M15b, M15c, M15d, M15e, M15f, M15g, M15h, M15i, M16, M17a, M17b, M17c, M17d, M17e, M17f, M17g, M17h, M17i, M18, M19, M20a, M20b, M21, M22, M23a1, M23b1, M23a2, M23b2, M23a3, M23b3, M23a4, M23b4, M23a5, M23b5, M23a6, M23b6, M23a7, M23b7, M23a8, M23b8, M23a9, M23b9, M24, M25a, M25b, M26, M26a, M26b, M27, M27a, M27b, M28
Page Medical_Intro Show if Q21 Medical user past 12 months
You indicated that you have used cannabis for medical purposes. Would you be willing to complete a series of questions asking about your use of cannabis for medical purposes?
Please remember that you can stop the survey and return at a later time.
Page Medical_Usage Show if Mcontinue Yes
In this series of questions when we use the term cannabis, this includes marijuana, hashish, hash oil or any other products made from the cannabis plant, but not synthetic cannabinoids.
When we ask about use, this includes using cannabis in its dry form or when mixed or processed into another product such as an edible, concentrate, liquid, or other product for medical purposes.
By medical purposes we mean used to treat a disease/disorder or to improve symptoms associated with a disease/disorder.
M1 Show if Q21 Yes with medical document
How do you access cannabis for medical purposes?
Select all that apply
M2 Show if Q21 Medical user past 12 months
Are you currently covered by insurance for cannabis for medical purposes?
M3 Show if Q21 Medical user past 12 months
In the past 12 months, how often did you typically use cannabis for medical purposes?
M4 Show if Q21 Medical user past 12 months
During the past 12 months, what type of effect did your cannabis use for medical purposes have on your:
Levels marked with * are randomized
M5 Show if Q21 Medical user past 12 months
For which of the following diseases/disorders do you use cannabis for medical purposes?
Select all that apply
M6 Show if Q21 Medical user past 12 months
For which of the following symptoms do you use cannabis for medical purposes?
Select all that apply
M7a Show if Q21 Medical user past 12 months
Has your use of cannabis for medical purposes allowed you to decrease your use of any other medications?
M7b Show if M7a Yes decreased other medications
Which medication(s) have you been able to reduce your use of since starting to use cannabis for medical purposes?
Select all that apply
M8 Show if Q21 Medical user past 12 months
Has your use of cannabis for medical purposes changed your consumption of the following substances?
M9 Show if Q21 Medical user past 12 months
In the past 12 months, where did you get the cannabis you used for medical purposes?
Select all that apply
M9a Show if M9 5 Medical cannabis seller
Will you continue to directly access cannabis from a federally licensed seller for medical purposes that you are registered with, now that legal retail outlets and online sales are available for non-medical cannabis?
M9b Show if M9 1 Grow my own OR 2 Grown for me
Are you currently authorized by Health Canada to grow cannabis for medical purposes?
M10a Show if Q21 Medical user past 12 months
In the past 12 months, how often did you buy or receive any cannabis for medical purposes from a legal/licensed source?
M10b Show if M10a 1 2 3 or 4
What were these legal/licensed sources?
Select all that apply
M10c Show if M10b 3 Someone shared with you
Did you pay the person(s) for the cannabis they shared with you?
M11a Show if Q21 Medical user past 12 months AND M10a NOT always
In the past 12 months, how often did you buy or receive any cannabis for medical purposes from an illegal/unlicensed source?
M11b Show if M11a 1 2 3 or 4
What were these illegal/unlicensed sources?
Select all that apply
M12 Show if Q21 Medical user past 12 months
In the past 12 months, did you use the following method to consume cannabis for medical purposes?
Select all that apply
M12a Show if M12 5 Vapourized with a portable OR 4 Non portable device
What cannabis products did you use when vapourizing cannabis?
Select all that apply
M12b Show if M12 5 Vapourized with a portable vaping device
What type of portable vaping device did you use when vapourizing cannabis?
M13 Show if Q21 Medical user past 12 months
When choosing cannabis products for medical purposes, what levels of THC and CBD do you typically use?
M14 Show if Q21 Medical user past 12 months
In the past 12 months, have you used the following cannabis products for medical purposes?
Select all that apply
M15a Show if M14 1 Used Dried flower past 12 months
When choosing cannabis products for medical purposes, what levels of THC and CBD do you typically use for:
Dried flower/leaf?
Please make a selection in each of the CBD and THC sections.
THC Levels
CBD Levels
M15b Show if M14 2 Used Hashish kief past 12 months
When choosing cannabis products for medical purposes, what levels of THC and CBD do you typically use for:
Hashish/kief?
Please make a selection in each of the CBD and THC sections.
THC Levels
CBD Levels
M15c Show if M14 3 Used Cannabis oil for oral past 12 months
When choosing cannabis products for medical purposes, what levels of THC and CBD do you typically use for:
Cannabis oil for oral use - e.g., in dropper/syringe, softgel/capsules, spray bottle?
Please make a selection in each of the CBD and THC sections.
THC Levels
CBD Levels
M15d Show if M14 4 Used Cannabis vape pens past 12 months
When choosing cannabis products for medical purposes, what levels of THC and CBD do you typically use for:
Cannabis vape pens/cartridges?
Please make a selection in each of the CBD and THC sections.
THC Levels
CBD Levels
M15e Show if M14 5 Used Cannabis concentrate past 12 months
When choosing cannabis products for medical purposes, what levels of THC and CBD do you typically use for:
Cannabis concentrate/extracts - e.g., shatter/wax/budder/butane honey oil?
Please make a selection in each of the CBD and THC sections.
THC Levels
CBD Levels
M15f Show if M14 6 Used Cannabis edibles past 12 months
When choosing cannabis products for medical purposes, what levels of THC and CBD do you typically use for:
Cannabis edible food products - e.g., cookies, candy?
Please make a selection in each of the CBD and THC sections.
THC Levels
CBD Levels
M15g Show if M14 7 Used Cannabis beverages past 12 months
When choosing cannabis products for medical purposes, what levels of THC and CBD do you typically use for:
Cannabis beverages - e.g., sparkling water, tea, dissolvable powder?
Please make a selection in each of the CBD and THC sections.
THC Levels
CBD Levels
M15h Show if M14 8 Used Topicals past 12 months
When choosing cannabis products for medical purposes, what levels of THC and CBD do you typically use for:
Topicals - e.g., lotion, ointment, creams applied to skin?
Please make a selection in each of the CBD and THC sections.
THC Levels
CBD Levels
M15i Show if M14 9 Used Other past 12 months
When choosing cannabis products for medical purposes, what levels of THC and CBD do you typically use for:
Other: <<M14.specify(9)>>?
Please make a selection in each of the CBD and THC sections.
THC Levels
CBD Levels
M16 Show if Q21 Medical user past 12 months
In the past 12 months, how often have you used the following cannabis products for medical purposes?
M17a Show if M14 1 Used Dried flower past 12 months
On the days that you used:
Dried flower/leaf for medical purposes, how much did you typically use in a day?
Please select the amount closest to what you typically use
M17b Show if M14 2 Used Hashish kief past 12 months
On the days that you used:
Hashish/kief for medical purposes, how much did you typically use in a day?
Please select the amount closest to what you typically use
M17c Show if M14 3 Used Cannabis oil for oral past 12 months
On the days that you used:
Cannabis oil for oral use - e.g., in dropper/syringe, softgel/capsules, spray bottle for medical purposes, how much did you typically use in a day?
Please select the amount closest to what you typically use
M17d Show if M14 4 Used Cannabis vape pens past 12 months
On the days that you used:
Cannabis vape pens/cartridges for medical purposes, how much did you typically use in a day?
Please select the amount closest to what you typically use
M17e Show if M14 5 Used Cannabis concentrate past 12 months
On the days that you used:
Cannabis concentrate/extracts - e.g., shatter/wax/budder/butane honey oil for medical purposes, how much did you typically use in a day?
Please select the amount closest to what you typically use
M17f Show if M14 6 Used Cannabis edibles past 12 months
On the days that you used:
Cannabis edible food products - e.g., cookies, candy for medical purposes, how much did you typically use in a day?
Please select the amount closest to what you typically use
M17g Show if M14 7 Used Cannabis beverages past 12 months
On the days that you used:
Cannabis beverages - e.g., sparkling water, tea, dissolvable powder for medical purposes, how much did you typically use in a day (including any liquid that the product is mixed with)?
Please select the amount closest to what you typically use
M17h Show if M14 8 Used Topicals past 12 months
On the days that you used:
Topicals - e.g., lotion, ointment, creams applied to skin for medical purposes, how much did you typically use in a day?
Please do not enter personally-identifying information.
M17i Show if M14 9 Used Other past 12 months
On the days that you used:
Other: <<M14.specify(9)>> for medical purposes, how much did you typically use in a day?
Please do not enter personally-identifying information.
M18 Show if Q21 Medical user past 12 months
How much do you typically spend on cannabis for medical purposes each month?
Minimum: 0.0, Maximum: 1000.0
__________ Enter estimated dollar amount
M19 Show if Q21 Medical user past 12 months
In the past 30 days, have you used cannabis for medical purposes (used to treat disease/disorder or improve symptoms)?
M20a Show if M19 Medical user past 30 days
In the past 30 days, how much did you spend on cannabis for medical purposes obtained from a legal source?
Minimum: 0.0, Maximum: 1000.0
__________ Enter estimated dollar amount
M20b Show if M19 Medical user past 30 days
In the past 30 days, how much did you spend on cannabis for medical purposes obtained from an illegal source?
Minimum: 0.0, Maximum: 1000.0
__________ Enter estimated dollar amount
M21 Show if M19 Medical user past 30 days
In the past 30 days, which forms of cannabis have you bought or received for medical purposes?
Select all that apply
M22 Show if M19 Medical user past 30 days
In the past 30 days, how often did you buy or receive cannabis for medical purposes?
M23a1 Show if M21 1 Used Dried flower past 30 days
Typically, how much cannabis in the form:
Dried flower/leaf did you buy or receive each time for medical purposes?
Please select the amount closest to what you typically bought or received each time.
M23b1 Show if M21 1 Used Dried flower past 30 days
How much did you pay for this amount?
Minimum: 0.0, Maximum: 1000.0
__________ Enter dollar amount
M23a2 Show if M21 2 Used Hashish kief past 30 days
Typically, how much cannabis in the form:
Hashish/kief did you buy or receive each time for medical purposes?
M23b2 Show if M21 2 Used Hashish kief past 30 days
How much did you pay for this amount?
Minimum: 0.0, Maximum: 1000.0
__________ Enter dollar amount
M23a3 Show if M21 3 Used Cannabis oil for oral past 30 days
Typically, how much cannabis in the form:
Cannabis oil for oral use - e.g., in dropper/syringe, softgel/capsules, spray bottle did you buy or receive each time for medical purposes?
M23b3 Show if M21 3 Used Cannabis oil for oral past 30 days
How much did you pay for this amount?
Minimum: 0.0, Maximum: 1000.0
__________ Enter dollar amount
M23a4 Show if M21 4 Used Cannabis vape pens past 30 days
Typically, how much cannabis in the form:
Cannabis vape pens/cartridges did you buy or receive each time for medical purposes?
M23b4 Show if M21 4 Used Cannabis vape pens past 30 days
How much did you pay for this amount?
Minimum: 0.0, Maximum: 1000.0
__________ Enter dollar amount
M23a5 Show if M21 5 Used Cannabis concentrate past 30 days
Typically, how much cannabis in the form:
Cannabis concentrate/extracts - e.g., shatter/wax/budder/butane honey oil did you buy or receive each time for medical purposes?
M23b5 Show if M21 5 Used Cannabis concentrate past 30 days
How much did you pay for this amount?
Minimum: 0.0, Maximum: 1000.0
__________ Enter dollar amount
M23a6 Show if M21 6 Used Cannabis edibles past 30 days
Typically, how much cannabis in the form:
Cannabis edible food products - e.g., cookies, candy did you buy or receive each time for medical purposes?
M23b6 Show if M21 6 Used Cannabis edibles past 30 days
How much did you pay for this amount?
Minimum: 0.0, Maximum: 1000.0
__________ Enter dollar amount
M23a7 Show if M21 7 Used Cannabis beverage past 30 days
Typically, how much cannabis in the form:
Cannabis beverages - e.g., sparkling water, tea, dissolvable powder did you buy or receive each time for medical purposes?
M23b7 Show if M21 7 Used Cannabis beverage past 30 days
How much did you pay for this amount?
Minimum: 0.0, Maximum: 1000.0
__________ Enter dollar amount
M23a8 Show if M21 8 Used Topicals past 30 days
Typically, how much cannabis in the form:
Topicals - e.g., lotion, ointment, creams applied to skin did you buy or receive each time for medical purposes?
Please do not enter personally-identifying information.
M23b8 Show if M21 8 Used Topicals past 30 days
How much did you pay for this amount?
Minimum: 0.0, Maximum: 1000.0
__________ Enter dollar amount
M23a9 Show if M21 9 Used Other past 30 days
Typically, how much cannabis in the form:
Other: <<M21.specify(9)>> did you buy or receive each time for medical purposes?
Please do not enter personally-identifying information.
M23b9 Show if M21 9 Used Other past 30 days
How much did you pay for this amount?
Minimum: 0.0, Maximum: 1000.0
__________ Enter dollar amount
M24 Show if Q21 Medical user past 12 months
In your opinion, does using cannabis for medical purposes impair one's ability to drive or operate a motor vehicle?
M25a Show if Q21 Medical user past 12 months
As far as you know, when is it safe for someone to drive a motor vehicle after inhaling (smoking/vaping) cannabis for medical purposes?
M25b Show if Q21 Medical user past 12 months
As far as you know, when is it safe for someone to drive a motor vehicle after ingesting (eating/drinking) cannabis for medical purposes?
M26 Show if Q21 Medical user past 12 months
Have you driven a motor vehicle (e.g., car, snowmobile, motor boat or all-terrain vehicle (ATV)) within 2 hours of smoking or vapourizing cannabis or a cannabis product for medical purposes?
M26a Show if M26 Yes driven within 2hrs of smoking vaping
When did this last happen?
M26b Show if M26 Yes AND M26 within past 30 days
What type of cannabis product was it?
M27 Show if Q21 Medical user past 12 months
Have you driven a motor vehicle (e.g., car, snowmobile, motor boat or all-terrain vehicle (ATV)) within 4 hours of ingesting a cannabis product (e.g., cannabis food/beverages, capsules) for medical purposes?
M27a Show if M27 Yes driven within 4hrs of eating
When did this last happen?
M27b Show if M27 Yes AND M27a within past 30 days
What type of cannabis product was it?
M28 Show if M26 Yes driven 2hrs smoking vaping OR M27 yes driven 4hrs eating
Why did you drive a motor vehicle after using cannabis for medical purposes?
Select all that apply
Section Ending
F1, End1
Page Ends
F1
Finally, would you be willing to participate in this study again in the future?
End1
You have now completed the survey
Thank you very much for participating in this survey.
Status Code: -1